13F-HR filed by ARCH Venture Management, LLC
ARCH Venture Management, LLC filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 12 holding rows worth $1,100,261,770.
- Accession
- 0001012975-26-000794
- Filer
- CIK 1274403
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 12 entries on the cover page, a total value of $1,100,261,770 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,100,261,770 with VALUE read as dollars as filed, 13F file number 028-19358. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 6,412,780 | $175,517,789 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 4,540,132 | $155,771,929 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 3,728,738 | $155,376,512 | dollars as filed | |
| SEAPORT THERAPEUTICS INC | 81221K108 | COMMON STOCK | 6,294,951 | $136,600,437 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 7,091,557 | $129,917,324 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 12,694,163 | $129,353,521 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 4,120,053 | $122,983,582 | dollars as filed | |
| LYELL IMMUNOPHARMA INC COM NEW | 55083R203 | Stock | 3,247,162 | $45,525,211 | dollars as filed | |
| GENERATE BIOMEDICINES INC | 370920100 | COMMON STOCK | 1,944,426 | $32,802,467 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 217,834 | $8,351,756 | dollars as filed | |
| BOUNDLESS BIO INC | 10170A100 | COM | 2,694,095 | $6,735,238 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 8,055,916 | $1,326,004 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001012975-26-000794 | this filing | 2026-08-14 | acceptance time not in the bulk data set |